WallStreetZenWallStreetZen

Sectors & IndustriesHealthcareBiotechnology
Best Biotech Stocks to Buy Now (2024)
Top biotech stocks in 2024 ranked by overall Zen Score. See the best biotech stocks to buy now, according to analyst forecasts for the biotechnology industry.

Industry: Biotechnology
Ticker
Company
Exchange
Industry
Zen Score
Market Cap
Price
1d %
EBITDA
P/E
D/E
SNGX
SOLIGENIX INC
NASDAQ
Biotechnology
$4.36M$0.41-0.24%-$7.74M-0.52x2.88
ADVM
ADVERUM BIOTECHNOLOGIES INC
NASDAQ
Biotechnology
$197.79M$9.533.70%-$99.57M-0.82x1.07
INBX
INHIBRX INC
NASDAQ
Biotechnology
$1.62B$34.160.29%-$206.56M-6.67x6.08
CGTX
COGNITION THERAPEUTICS INC
NASDAQ
Biotechnology
$75.27M$1.93-1.03%-$25.51M-2.24x0.44
XLO
XILIO THERAPEUTICS INC
NASDAQ
Biotechnology
$35.85M$1.04-4.59%-$74.50M-0.37x0.65
BHVN
BIOHAVEN LTD
NYSE
Biotechnology
$3.25B$39.832.21%-$402.64M-6.95x0.20
CERE
CEREVEL THERAPEUTICS HOLDINGS INC
NASDAQ
Biotechnology
$7.76B$42.750.66%-$416.15M-16.01x0.85
FHTX
FOGHORN THERAPEUTICS INC
NASDAQ
Biotechnology
$243.90M$5.734.37%-$85.54M-2.45x-4.70
REVB
REVELATION BIOSCIENCES INC
NASDAQ
Biotechnology
$3.46M$2.12-2.75%-$95.21k-4.00x0.84
AIM
AIM IMMUNOTECH INC
NYSEMKT
Biotechnology
$20.56M$0.41-3.74%-$28.44M-0.69x0.89
FRES
FRESH2 GROUP LTD
NASDAQ
Biotechnology
$4.51M$0.50-13.30%N/A-0.15x0.72
CKPT
CHECKPOINT THERAPEUTICS INC
NASDAQ
Biotechnology
$51.21M$1.440.35%-$51.85M-0.45x-1.41
BDRX
BIODEXA PHARMACEUTICALS PLC
NASDAQ
Biotechnology
$6.68M$1.310.77%-$8.84M-0.13x1.25
TPST
TEMPEST THERAPEUTICS INC
NASDAQ
Biotechnology
$76.34M$3.44-2.82%-$25.96M-1.80x0.93
ALNY
ALNYLAM PHARMACEUTICALS INC
NASDAQ
Biotechnology
$18.56B$147.362.83%-$215.27M-41.86x-18.36
PROK
PROKIDNEY CORP
NASDAQ
Biotechnology
$527.49M$2.308.49%-$25.61M-4.04x-0.03
CDMO
AVID BIOSERVICES INC
NASDAQ
Biotechnology
$479.91M$7.562.86%-$7.83M-27.00x1.53
CGEN
COMPUGEN LTD
NASDAQ
Biotechnology
$175.06M$1.983.13%N/A-9.43x0.85
TRVN
TREVENA INC
NASDAQ
Biotechnology
$7.33M$0.402.30%-$35.99M-0.13x-6.30
GYRE
GYRE THERAPEUTICS INC
NASDAQ
Biotechnology
$1.40B$16.43-3.97%-$82.99M-11.65x-2.41
CYTK
CYTOKINETICS INC
NASDAQ
Biotechnology
$6.44B$62.53-4.30%-$486.05M-11.47x-3.13
CELU
CELULARITY INC
NASDAQ
Biotechnology
$58.13M$3.00-0.66%-$169.66M-0.30x4.20
MCRB
SERES THERAPEUTICS INC
NASDAQ
Biotechnology
$137.27M$0.9110.18%-$85.43M-1.02x-8.99
AVBP
ARRIVENT BIOPHARMA INC
NASDAQ
Biotechnology
$499.48M$16.345.83%-$69.33M-0.50x-0.08
PRTG
PORTAGE BIOTECH INC
NASDAQ
Biotechnology
$5.14M$0.268.33%-$170.35M-0.03x0.55
INAB
IN8BIO INC
NASDAQ
Biotechnology
$42.85M$0.99-4.81%-$27.51M-0.99x0.35
OGEN
ORAGENICS INC
NYSEMKT
Biotechnology
$4.53M$1.01-1.94%-$20.60M-0.11x0.57
NVCT
NUVECTIS PHARMA INC
NASDAQ
Biotechnology
$113.37M$6.38-1.85%-$22.26M-4.46x0.57
BCDA
BIOCARDIA INC
NASDAQ
Biotechnology
$9.89M$0.37-1.86%-$11.16M-0.67x-2.86
ELEV
ELEVATION ONCOLOGY INC
NASDAQ
Biotechnology
$187.31M$3.856.35%-$45.64M-2.87x0.63
CDXS
CODEXIS INC
NASDAQ
Biotechnology
$214.43M$3.0514.66%-$66.25M-2.72x0.58
LIXT
LIXTE BIOTECHNOLOGY HOLDINGS INC
NASDAQ
Biotechnology
$7.06M$3.14-3.68%-$5.07M-1.18x0.08
SAVA
CASSAVA SCIENCES INC
NASDAQ
Biotechnology
$963.92M$22.30-0.18%-$95.69M-9.61x0.10
PHIO
PHIO PHARMACEUTICALS CORP
NASDAQ
Biotechnology
$3.10M$0.68-1.03%-$10.64M-0.13x0.21
LCTX
LINEAGE CELL THERAPEUTICS INC
NYSEMKT
Biotechnology
$211.16M$1.12-1.75%-$22.60M-9.33x0.62
ANL
ADLAI NORTYE LTD
NASDAQ
Biotechnology
$545.58M$14.807.64%-$101.22M-2.04x0.64
SMMT
SUMMIT THERAPEUTICS INC
NASDAQ
Biotechnology
$2.72B$3.880.52%-$612.88M-388.00x1.61
BOLD
BOUNDLESS BIO INC
NASDAQ
Biotechnology
N/A$11.46-1.55%-$46.12M-0.28x-0.07
VSTM
VERASTEM INC
NASDAQ
Biotechnology
$243.60M$9.632.67%-$83.34M-2.43x1.24
IMUX
IMMUNIC INC
NASDAQ
Biotechnology
$110.61M$1.230.82%-$93.50M-0.58x0.88
CARA
CARA THERAPEUTICS INC
NASDAQ
Biotechnology
$41.27M$0.7610.38%-$115.58M-0.34x1.21
CYBN
CYBIN INC
NYSEMKT
Biotechnology
$143.93M$0.350.00%-$51.93M-1.69x0.07
NEXI
NEXIMMUNE INC
NASDAQ
Biotechnology
$4.50M$3.28-2.67%-$30.78M-0.11x1.45
IMNN
IMUNON INC
NASDAQ
Biotechnology
$12.74M$1.36-5.90%-$19.88M-0.63x0.64
BIOR
BIORA THERAPEUTICS INC
NASDAQ
Biotechnology
$18.89M$0.62-0.80%-$113.84M-0.08x-1.31
KOD
KODIAK SCIENCES INC
NASDAQ
Biotechnology
$176.95M$3.372.74%-$234.53M-0.68x0.80
VANI
VIVANI MEDICAL INC
NASDAQ
Biotechnology
$89.61M$1.630.00%-$24.39M-3.26x1.21
APLM
APOLLOMICS INC
NASDAQ
Biotechnology
$39.38M$0.44-2.22%-$171.77M-0.19x0.34
VERU
VERU INC
NASDAQ
Biotechnology
$182.98M$1.25-1.57%-$62.11M-1.67x0.56
NBSE
NEUBASE THERAPEUTICS INC
NASDAQ
Biotechnology
$1.56M$0.42-5.00%-$12.55M-0.05x1.04
CNTX
CONTEXT THERAPEUTICS INC
NASDAQ
Biotechnology
$21.87M$1.37-2.84%-$23.90M-0.91x0.35
INDP
INDAPTUS THERAPEUTICS INC
NASDAQ
Biotechnology
$18.12M$2.120.57%-$15.42M-1.16x0.24
NBY
NOVABAY PHARMACEUTICALS INC
NYSEMKT
Biotechnology
$2.50M$0.085.06%-$9.44M-0.02x1.73
NAMS
NEWAMSTERDAM PHARMA CO NV
NASDAQ
Biotechnology
$1.93B$21.66-1.50%-$192.24M-9.27x0.20
MNMD
MIND MEDICINE (MINDMED) INC
NASDAQ
Biotechnology
$373.25M$9.035.99%-$92.57M-3.70x0.59
ASMB
ASSEMBLY BIOSCIENCES INC
NASDAQ
Biotechnology
$70.73M$12.901.98%-$60.75M-0.96x2.33
MNPR
MONOPAR THERAPEUTICS
NASDAQ
Biotechnology
$11.35M$0.65-1.22%-$8.40M-1.07x0.32
XRTX
XORTX THERAPEUTICS INC
NASDAQ
Biotechnology
$5.29M$2.65-9.73%-$5.58M-0.85x0.09
CALC
CALCIMEDICA INC
NASDAQ
Biotechnology
$59.02M$5.500.83%-$34.30M-0.72x0.49
TIL
INSTIL BIO INC
NASDAQ
Biotechnology
$68.13M$10.48-1.18%-$145.48M-0.44x0.44
KYTX
KYVERNA THERAPEUTICS INC
NASDAQ
Biotechnology
$647.16M$15.01-2.97%-$56.75M-0.17x-0.20
ESLA
ESTRELLA IMMUNOPHARMA INC
NASDAQ
Biotechnology
$39.14M$1.074.80%-$8.36M-0.37x0.04
FBLG
FIBROBIOLOGICS INC
NASDAQ
Biotechnology
$344.29M$10.554.35%-$15.90M-15.51x8.43
PXMD
PAXMEDICA INC
NASDAQ
Biotechnology
$5.49M$0.740.14%-$18.28M-0.07x0.68
KALV
KALVISTA PHARMACEUTICALS INC
NASDAQ
Biotechnology
$464.49M$11.012.13%-$107.49M-3.52x0.29
COEP
COEPTIS THERAPEUTICS HOLDINGS INC
NASDAQ
Biotechnology
$12.09M$0.340.00%-$20.16M-0.40x0.87
ANRO
ALTO NEUROSCIENCE INC
NYSE
Biotechnology
$418.31M$15.569.73%-$34.28M-1.60x-0.24
SCPX
SCORPIUS HOLDINGS INC
NYSEMKT
Biotechnology
$7.57M$0.2124.26%-$36.93M-0.12x0.72
TSVT
2SEVENTY BIO INC
NASDAQ
Biotechnology
$235.52M$4.597.87%-$207.29M-1.04x1.22
VERA
VERA THERAPEUTICS INC
NASDAQ
Biotechnology
$2.25B$41.384.36%-$94.07M-18.39x0.73
VAXX
VAXXINITY INC
NASDAQ
Biotechnology
$19.39M$0.1530.77%-$54.00M-0.34x2.31
MDGL
MADRIGAL PHARMACEUTICALS INC
NASDAQ
Biotechnology
$4.00B$201.074.00%-$360.39M-10.06x0.58
ADXN
ADDEX THERAPEUTICS LTD
NASDAQ
Biotechnology
$7.55M$7.54-53.17%-$11.01M-48.33x3.05
ALRN
AILERON THERAPEUTICS INC
NASDAQ
Biotechnology
$83.50M$4.92-1.60%-$15.61M-1.44x1.12
AGEN
AGENUS INC
NASDAQ
Biotechnology
$267.27M$12.769.15%-$134.25M-0.92x-2.88
AKBA
AKEBIA THERAPEUTICS INC
NASDAQ
Biotechnology
$276.37M$1.32-1.49%-$4.05M-4.71x-8.90
AVTX
AVALO THERAPEUTICS INC
NASDAQ
Biotechnology
$17.46M$16.885.90%-$27.96M-0.15x1.87
PTCT
PTC THERAPEUTICS INC
NASDAQ
Biotechnology
$2.47B$32.1412.50%-$245.30M-4.18x-3.00
KZIA
KAZIA THERAPEUTICS LTD
NASDAQ
Biotechnology
$9.36M$0.36-4.05%N/A-0.97x3.63
OMER
OMEROS CORP
NASDAQ
Biotechnology
$181.36M$3.13-0.63%-$86.05M-1.66x-16.14
BBIO
BRIDGEBIO PHARMA INC
NASDAQ
Biotechnology
$4.48B$25.472.37%-$551.39M-6.45x-1.40
EVAX
EVAXION BIOTECH A
NASDAQ
Biotechnology
$16.26M$4.292.63%-$21.23M-0.53x-3.73
DARE
DARE BIOSCIENCE INC
NASDAQ
Biotechnology
$28.36M$0.28-7.84%-$30.07M-0.81x-5.22
GUTS
FRACTYL HEALTH INC
NASDAQ
Biotechnology
$334.19M$6.984.18%-$76.81M-0.15x-0.35
FGEN
FIBROGEN INC
NASDAQ
Biotechnology
$107.66M$1.094.81%-$258.77M-0.37x-2.87
NTRB
NUTRIBAND INC
NASDAQ
Biotechnology
$26.79M$3.42-3.66%-$4.92M-5.10x0.49
PHGE
BIOMX INC
NYSEMKT
Biotechnology
$20.98M$0.388.57%-$22.87M-0.75x7.12
CVM
CEL SCI CORP
NYSEMKT
Biotechnology
$70.65M$1.41-2.08%-$26.34M-2.04x1.27
CERO
CERO THERAPEUTICS HOLDINGS INC
NASDAQ
Biotechnology
$20.47M$1.391.46%-$2.44M-3.56x-1.01
MYMD
MYMD PHARMACEUTICALS INC
NASDAQ
Biotechnology
$6.26M$2.902.11%-$4.00M-0.54x0.41
PRME
PRIME MEDICINE INC
NASDAQ
Biotechnology
$582.90M$4.869.83%-$180.97M-2.23x0.46
MBIO
MUSTANG BIO INC
NASDAQ
Biotechnology
$2.46M$0.24-25.00%-$45.27M-0.04x143.24
WINT
WINDTREE THERAPEUTICS INC
NASDAQ
Biotechnology
$2.70M$5.301.34%-$19.75M-0.06x8.56
BPTH
BIO-PATH HOLDINGS INC
NASDAQ
Biotechnology
$1.93M$2.856.34%-$15.90M-0.08x6.30
RENB
RENOVARO INC
NASDAQ
Biotechnology
$224.12M$1.561.96%-$40.26M-2.23x0.33
CTCX
CARMELL CORP
NASDAQ
Biotechnology
$38.49M$2.00-4.31%-$14.47M-1.37x1.58
GRI
GRI BIO INC
NASDAQ
Biotechnology
$1.37M$0.430.00%-$10.95M-0.02x10.41
LBPH
LONGBOARD PHARMACEUTICALS INC
NASDAQ
Biotechnology
$764.65M$21.237.66%-$54.42M-8.88x0.24
RNAZ
TRANSCODE THERAPEUTICS INC
NASDAQ
Biotechnology
$3.41M$0.596.73%-$17.97M-0.01x2.15
ITRM
ITERUM THERAPEUTICS PLC
NASDAQ
Biotechnology
$25.30M$1.54-7.78%-$34.58M-0.52x-5.10

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Apr 2024?

According to Zen Score, the 3 best biotechnology stocks to buy right now are:

1. Incyte (NASDAQ:INCY)


Incyte (NASDAQ:INCY) is the top biotech stock with a Zen Score of 75, which is 52 points higher than the biotech industry average of 23. It passed 24 out of 33 due diligence checks and has strong fundamentals. Incyte has seen its stock lose -30.24% over the past year, underperforming other biotech stocks by -8 percentage points.

Incyte has an average 1 year price target of $74.69, an upside of 42.11% from Incyte's current stock price of $52.56.

Incyte stock has a consensus Buy recommendation according to Wall Street analysts. Of the 13 analysts covering Incyte, 23.08% have issued a Strong Buy rating, 23.08% have issued a Buy, 53.85% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Harmony Biosciences Holdings (NASDAQ:HRMY)


Harmony Biosciences Holdings (NASDAQ:HRMY) is the second best biotech stock with a Zen Score of 70, which is 47 points higher than the biotech industry average of 23. It passed 23 out of 33 due diligence checks and has strong fundamentals. Harmony Biosciences Holdings has seen its stock lose -10.71% over the past year, overperforming other biotech stocks by 12 percentage points.

Harmony Biosciences Holdings has an average 1 year price target of $37.33, an upside of 27.63% from Harmony Biosciences Holdings's current stock price of $29.25.

Harmony Biosciences Holdings stock has a consensus Buy recommendation according to Wall Street analysts. Of the 6 analysts covering Harmony Biosciences Holdings, 33.33% have issued a Strong Buy rating, 33.33% have issued a Buy, 0% have issued a hold, while 16.67% have issued a Sell rating, and 16.67% have issued a Strong Sell.

3. Voyager Therapeutics (NASDAQ:VYGR)


Voyager Therapeutics (NASDAQ:VYGR) is the third best biotech stock with a Zen Score of 66, which is 43 points higher than the biotech industry average of 23. It passed 21 out of 33 due diligence checks and has strong fundamentals. Voyager Therapeutics has seen its stock return 7.32% over the past year, overperforming other biotech stocks by 30 percentage points.

Voyager Therapeutics has an average 1 year price target of $20.50, an upside of 163.84% from Voyager Therapeutics's current stock price of $7.77.

Voyager Therapeutics stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Voyager Therapeutics, 75% have issued a Strong Buy rating, 25% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 4 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Carisma Therapeutics (NASDAQ:CARM)


Carisma Therapeutics (NASDAQ:CARM) has an annual dividend yield of N/A, which is N/A percentage points lower than the biotech industry average of 14.95%.

Carisma Therapeutics's dividend payout ratio of 0% indicates that its dividend yield might not be sustainable for the long-term.

2. Mei Pharma (NASDAQ:MEIP)


Mei Pharma (NASDAQ:MEIP) has an annual dividend yield of 56.82%, which is 42 percentage points higher than the biotech industry average of 14.95%.

Mei Pharma's dividend payout ratio of 58.9% indicates that its high dividend yield is sustainable for the long-term.

3. Novo Nordisk A S (NYSE:NVO)


Novo Nordisk A S (NYSE:NVO) has an annual dividend yield of 1.08%, which is -14 percentage points lower than the biotech industry average of 14.95%. Novo Nordisk A S's dividend payout is not stable, having dropped more than 10% eight times in the last 10 years. Novo Nordisk A S's dividend has shown consistent growth over the last 10 years.

Novo Nordisk A S's dividend payout ratio of 38.1% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks up?

Biotech stocks were up 1.46% in the last day, and up 1.78% over the last week. Immunitybio was the among the top gainers in the biotechnology industry, gaining 22.31% yesterday.

ImmunityBio shares are trading higher after Piper Sandler maintained a Neutral rating on the stock and raised its price target from $5 to $6.

What are the most undervalued biotech stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued biotech stocks right now are:

1. Royalty Pharma (NASDAQ:RPRX)


Royalty Pharma (NASDAQ:RPRX) is the most undervalued biotech stock based on WallStreetZen's Valuation Score. Royalty Pharma has a valuation score of 100, which is 86 points higher than the biotech industry average of 14. It passed 7 out of 7 valuation due diligence checks.

Royalty Pharma's stock has dropped -20.41% in the past year. It has overperformed other stocks in the biotech industry by 2 percentage points.

2. Voyager Therapeutics (NASDAQ:VYGR)


Voyager Therapeutics (NASDAQ:VYGR) is the second most undervalued biotech stock based on WallStreetZen's Valuation Score. Voyager Therapeutics has a valuation score of 100, which is 86 points higher than the biotech industry average of 14. It passed 7 out of 7 valuation due diligence checks.

Voyager Therapeutics's stock has gained 7.32% in the past year. It has overperformed other stocks in the biotech industry by 30 percentage points.

3. Incyte (NASDAQ:INCY)


Incyte (NASDAQ:INCY) is the third most undervalued biotech stock based on WallStreetZen's Valuation Score. Incyte has a valuation score of 86, which is 72 points higher than the biotech industry average of 14. It passed 6 out of 7 valuation due diligence checks.

Incyte's stock has dropped -30.24% in the past year. It has underperformed other stocks in the biotech industry by -8 percentage points.

Are biotech stocks a good buy now?

49.42% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 88.66% over the next year.

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 14.39x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.